Cytomegalovirus (CMV) CD8 T-Cell Immune Competence, Quantitative Assessment by Flow Cytometry
Fees Several factors determine the fee charged to perform a test. Contact your U.S. or International Regional Manager for information about establishing a fee schedule or to learn more about resources to optimize test selection.
Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.
This test was developed using an analyte specific reagent. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.
CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
CPT codes are provided by the performing laboratory.
88184-Flow Cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; first marker
88185 x 2-Each additional marker
LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the order and result codes of this test.
LOINC codes are provided by the performing laboratory.
|Test ID||Test Order Name||Order LOINC Value|
|CMVC8||CMV CD8 T-Cell QN by Flow Cytometry||In Process|
|Result ID||Test Result Name||Result LOINC Value|
|28143||Total CD3 T cells||8122-4|
|28144||Total CD8 T cells||14135-8|
|28145||CMV CD8 T cells A1||In Process|
|28146||CMV CD8 T cells A2||In Process|
|28147||CMV CD8 T cells B7||In Process|
|28148||CMV CD8 T cells B8||In Process|
|28149||CMV CD8 T cells B35||In Process|
|28150||Total CMV CD8 T cells||In Process|
|28151||CMV CD8 T cells IFN-g A1||In Process|
|28152||CMV CD8 T cells IFN-g A2||In Process|
|28153||CMV CD8 T cells IFN-g B7||In Process|
|28154||CMV CD8 T cells IFN-g B8||In Process|
|28155||CMV CD8 T cells IFN-g B35||In Process|
|28156||Total CMV CD8 T cells IFN-g||In Process|
|28157||CMV CD8 T cells CD107 A1||In Process|
|28158||CMV CD8 T cells CD107 A2||In Process|
|28159||CMV CD8 T cells CD107 B7||In Process|
|28160||CMV CD8 T cells CD107 B8||In Process|
|28161||CMV CD8 T cells CD107 B35||In Process|
|28162||Total CMV CD8 T cells CD107a/b||In Process|
|30693||IFN-gamma expression||In Process|
|30694||CD107a/b expression||In Process|